CTI BioPharma Stock Price

-0.05 (-1.52%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CTI BioPharma Corporation CTIC NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.05 -1.52% 3.24 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.28 3.23 3.39 3.24 3.29
Bid Price Ask Price Spread News
3.26 3.36 0.10 1 -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,999 362,844 $ 3.30 $ 1,197,284 504,594 0.62 - 4.0322
Last Trade Time Type Quantity Stock Price Currency
19:56:56 49 $ 3.27 USD

CTI BioPharma Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 244.53M 75.47M 58.83M $ 3.35M $ - -0.69 -4.80
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

CTI BioPharma News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CTIC Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week3.503.543.233.37329,249-0.26-7.43%
1 Month3.633.643.173.39406,539-0.39-10.74%
3 Months3.404.03223.023.43595,777-0.16-4.71%
6 Months1.254.03220.96292.562,218,8371.99159.2%
1 Year1.354.03220.622.371,309,4171.89140.0%
3 Years3.485.36010.60012.33673,937-0.24-6.9%
5 Years11.6013.000.60013.33672,906-8.36-72.07%

CTI BioPharma Description

CTI BioPharma Corp is a biopharmaceutical company focused on the acquisition, development, and commercialization of less toxic and more effective cancer therapies. The company's therapeutic area is blood-related cancers. Its products under pipeline include PIXUVRI, and Pacritinib. PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. Pacritinib is an investigational oral kinase inhibitor for the treatment of adult patients with myelofibrosis.

Your Recent History
CTI BioPha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.